| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |